Diplon, Monica T.
HRN: 10-01-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/17/2022
05/23/2022
IVT
4.5g
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes